サマリー

婦人科癌治療薬の世界市場 2024-2028
婦人科癌治療薬市場は、2023-2028年に191億5000万米ドルで成長し、予測期間中のCAGRは15.83%で加速すると予測されます。この調査レポートは、婦人科癌治療薬市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析を掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。婦人科がんの罹患率の増加、強力なパイプラインと新薬承認、患者支援プログラムの増加などが市場を牽引しています。
Technavio社の婦人科癌治療薬市場は以下のように分類されます：
タイプ別
- 子宮がん
- 卵巣がん
- 子宮頸がん
- その他
治療法別
- 化学療法
- 標的療法
- ホルモン療法
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、今後数年間における婦人科がん治療薬市場の成長を促進する主な理由の1つとして、新規治療法の出現を挙げている。また、高度な診断モダリティの利用可能性と婦人科癌に対する意識の高まりは、市場の大きな需要につながる。
この調査レポートは、婦人科癌治療薬市場を調査・分析し、以下の刊行物を出版しています：
- 婦人科癌治療薬市場のサイジング
- 婦人科癌治療薬市場予測
- 婦人科癌治療薬市場の産業分析
強固なベンダー分析は、クライアントが市場での地位を向上できるように設計されており、これに沿って本レポートでは、AbbVie Inc.、Amgen Inc.、Apotex Inc.、AstraZeneca Plc、Bayer AG、Bristol Myers Squibb Co.、Cipla Ltd.、Eli Lilly and Co.、F. Hoffmann La Roche Ltd.、GlaxoSmithKline Plc、Hikma Pharmaceuticals Plc、Merck and Co.Inc.、ノバルティスAG、ファイザーInc.、サノフィSA、武田薬品工業Inc.Ltd.、テバ・ファーマシューティカル・インダストリーズLtd.などである。また、婦人科癌治療薬市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/gynecological-cancers-therapeutics-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Modality
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global gynecological cancers therapeutics market 2018 - 2022
o Exhibit 18: Historic Market Size - Data Table on global gynecological cancers therapeutics market 2018 - 2022 ($ billion)
o 4.2 Type Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
o 4.3 Modality Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - Modality Segment 2018 - 2022 ($ billion)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type - Market share 2023-2028 (%)
o Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Uterine cancer - Market size and forecast 2023-2028
o Exhibit 34: Chart on Uterine cancer - Market size and forecast 2023-2028 ($ billion)
o Exhibit 35: Data Table on Uterine cancer - Market size and forecast 2023-2028 ($ billion)
o Exhibit 36: Chart on Uterine cancer - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Uterine cancer - Year-over-year growth 2023-2028 (%)
o 6.4 Ovarian cancer - Market size and forecast 2023-2028
o Exhibit 38: Chart on Ovarian cancer - Market size and forecast 2023-2028 ($ billion)
o Exhibit 39: Data Table on Ovarian cancer - Market size and forecast 2023-2028 ($ billion)
o Exhibit 40: Chart on Ovarian cancer - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Ovarian cancer - Year-over-year growth 2023-2028 (%)
o 6.5 Cervical cancer - Market size and forecast 2023-2028
o Exhibit 42: Chart on Cervical cancer - Market size and forecast 2023-2028 ($ billion)
o Exhibit 43: Data Table on Cervical cancer - Market size and forecast 2023-2028 ($ billion)
o Exhibit 44: Chart on Cervical cancer - Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on Cervical cancer - Year-over-year growth 2023-2028 (%)
o 6.6 Others - Market size and forecast 2023-2028
o Exhibit 46: Chart on Others - Market size and forecast 2023-2028 ($ billion)
o Exhibit 47: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
o Exhibit 48: Chart on Others - Year-over-year growth 2023-2028 (%)
o Exhibit 49: Data Table on Others - Year-over-year growth 2023-2028 (%)
o 6.7 Market opportunity by Type
o Exhibit 50: Market opportunity by Type ($ billion)
o Exhibit 51: Data Table on Market opportunity by Type ($ billion)
• 7 Market Segmentation by Modality
o 7.1 Market segments
o Exhibit 52: Chart on Modality - Market share 2023-2028 (%)
o Exhibit 53: Data Table on Modality - Market share 2023-2028 (%)
o 7.2 Comparison by Modality
o Exhibit 54: Chart on Comparison by Modality
o Exhibit 55: Data Table on Comparison by Modality
o 7.3 Chemotherapy - Market size and forecast 2023-2028
o Exhibit 56: Chart on Chemotherapy - Market size and forecast 2023-2028 ($ billion)
o Exhibit 57: Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ billion)
o Exhibit 58: Chart on Chemotherapy - Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%)
o 7.4 Targeted therapy - Market size and forecast 2023-2028
o Exhibit 60: Chart on Targeted therapy - Market size and forecast 2023-2028 ($ billion)
o Exhibit 61: Data Table on Targeted therapy - Market size and forecast 2023-2028 ($ billion)
o Exhibit 62: Chart on Targeted therapy - Year-over-year growth 2023-2028 (%)
o Exhibit 63: Data Table on Targeted therapy - Year-over-year growth 2023-2028 (%)
o 7.5 Hormonal therapy - Market size and forecast 2023-2028
o Exhibit 64: Chart on Hormonal therapy - Market size and forecast 2023-2028 ($ billion)
o Exhibit 65: Data Table on Hormonal therapy - Market size and forecast 2023-2028 ($ billion)
o Exhibit 66: Chart on Hormonal therapy - Year-over-year growth 2023-2028 (%)
o Exhibit 67: Data Table on Hormonal therapy - Year-over-year growth 2023-2028 (%)
o 7.6 Market opportunity by Modality
o Exhibit 68: Market opportunity by Modality ($ billion)
o Exhibit 69: Data Table on Market opportunity by Modality ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 71: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 73: Chart on Geographic comparison
o Exhibit 74: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2023-2028
o Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.4 Europe - Market size and forecast 2023-2028
o Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 Germany - Market size and forecast 2023-2028
o Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
o 9.9 China - Market size and forecast 2023-2028
o Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
o 9.10 Canada - Market size and forecast 2023-2028
o Exhibit 103: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
o Exhibit 104: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
o Exhibit 105: Chart on Canada - Year-over-year growth 2023-2028 (%)
o Exhibit 106: Data Table on Canada - Year-over-year growth 2023-2028 (%)
o 9.11 UK - Market size and forecast 2023-2028
o Exhibit 107: Chart on UK - Market size and forecast 2023-2028 ($ billion)
o Exhibit 108: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
o Exhibit 109: Chart on UK - Year-over-year growth 2023-2028 (%)
o Exhibit 110: Data Table on UK - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 111: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 113: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 115: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 116: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 117: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 118: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 119: AbbVie Inc. - Overview
o Exhibit 120: AbbVie Inc. - Product / Service
o Exhibit 121: AbbVie Inc. - Key news
o Exhibit 122: AbbVie Inc. - Key offerings
o 12.4 Amgen Inc.
o Exhibit 123: Amgen Inc. - Overview
o Exhibit 124: Amgen Inc. - Product / Service
o Exhibit 125: Amgen Inc. - Key offerings
o 12.5 Apotex Inc.
o Exhibit 126: Apotex Inc. - Overview
o Exhibit 127: Apotex Inc. - Product / Service
o Exhibit 128: Apotex Inc. - Key offerings
o 12.6 AstraZeneca Plc
o Exhibit 129: AstraZeneca Plc - Overview
o Exhibit 130: AstraZeneca Plc - Product / Service
o Exhibit 131: AstraZeneca Plc - Key news
o Exhibit 132: AstraZeneca Plc - Key offerings
o 12.7 Bayer AG
o Exhibit 133: Bayer AG - Overview
o Exhibit 134: Bayer AG - Business segments
o Exhibit 135: Bayer AG - Key news
o Exhibit 136: Bayer AG - Key offerings
o Exhibit 137: Bayer AG - Segment focus
o 12.8 Bristol Myers Squibb Co.
o Exhibit 138: Bristol Myers Squibb Co. - Overview
o Exhibit 139: Bristol Myers Squibb Co. - Product / Service
o Exhibit 140: Bristol Myers Squibb Co. - Key news
o Exhibit 141: Bristol Myers Squibb Co. - Key offerings
o 12.9 Cipla Ltd.
o Exhibit 142: Cipla Ltd. - Overview
o Exhibit 143: Cipla Ltd. - Business segments
o Exhibit 144: Cipla Ltd. - Key news
o Exhibit 145: Cipla Ltd. - Key offerings
o Exhibit 146: Cipla Ltd. - Segment focus
o 12.10 Eli Lilly and Co.
o Exhibit 147: Eli Lilly and Co. - Overview
o Exhibit 148: Eli Lilly and Co. - Product / Service
o Exhibit 149: Eli Lilly and Co. - Key news
o Exhibit 150: Eli Lilly and Co. - Key offerings
o 12.11 F. Hoffmann La Roche Ltd.
o Exhibit 151: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 152: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 153: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 154: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 155: F. Hoffmann La Roche Ltd. - Segment focus
o 12.12 GlaxoSmithKline Plc
o Exhibit 156: GlaxoSmithKline Plc - Overview
o Exhibit 157: GlaxoSmithKline Plc - Business segments
o Exhibit 158: GlaxoSmithKline Plc - Key news
o Exhibit 159: GlaxoSmithKline Plc - Key offerings
o Exhibit 160: GlaxoSmithKline Plc - Segment focus
o 12.13 Hikma Pharmaceuticals Plc
o Exhibit 161: Hikma Pharmaceuticals Plc - Overview
o Exhibit 162: Hikma Pharmaceuticals Plc - Business segments
o Exhibit 163: Hikma Pharmaceuticals Plc - Key offerings
o Exhibit 164: Hikma Pharmaceuticals Plc - Segment focus
o 12.14 Merck and Co. Inc.
o Exhibit 165: Merck and Co. Inc. - Overview
o Exhibit 166: Merck and Co. Inc. - Business segments
o Exhibit 167: Merck and Co. Inc. - Key news
o Exhibit 168: Merck and Co. Inc. - Key offerings
o Exhibit 169: Merck and Co. Inc. - Segment focus
o 12.15 Novartis AG
o Exhibit 170: Novartis AG - Overview
o Exhibit 171: Novartis AG - Business segments
o Exhibit 172: Novartis AG - Key offerings
o Exhibit 173: Novartis AG - Segment focus
o 12.16 Pfizer Inc.
o Exhibit 174: Pfizer Inc. - Overview
o Exhibit 175: Pfizer Inc. - Product / Service
o Exhibit 176: Pfizer Inc. - Key news
o Exhibit 177: Pfizer Inc. - Key offerings
o 12.17 Sanofi SA
o Exhibit 178: Sanofi SA - Overview
o Exhibit 179: Sanofi SA - Business segments
o Exhibit 180: Sanofi SA - Key news
o Exhibit 181: Sanofi SA - Key offerings
o Exhibit 182: Sanofi SA - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 183: Inclusions checklist
o Exhibit 184: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 185: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 186: Research methodology
o Exhibit 187: Validation techniques employed for market sizing
o Exhibit 188: Information sources
o 13.5 List of abbreviations
o Exhibit 189: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Modality
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global gynecological cancers therapeutics market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Modality Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Type - Market share 2023-2028 (%)
Exhibits31: Data Table on Type - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Uterine cancer - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Uterine cancer - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Uterine cancer - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Uterine cancer - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Ovarian cancer - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Ovarian cancer - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Ovarian cancer - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Ovarian cancer - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Cervical cancer - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on Cervical cancer - Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on Cervical cancer - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Cervical cancer - Year-over-year growth 2023-2028 (%)
Exhibits46: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits47: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits48: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits49: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits50: Market opportunity by Type ($ billion)
Exhibits51: Data Table on Market opportunity by Type ($ billion)
Exhibits52: Chart on Modality - Market share 2023-2028 (%)
Exhibits53: Data Table on Modality - Market share 2023-2028 (%)
Exhibits54: Chart on Comparison by Modality
Exhibits55: Data Table on Comparison by Modality
Exhibits56: Chart on Chemotherapy - Market size and forecast 2023-2028 ($ billion)
Exhibits57: Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ billion)
Exhibits58: Chart on Chemotherapy - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on Targeted therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits61: Data Table on Targeted therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits62: Chart on Targeted therapy - Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Targeted therapy - Year-over-year growth 2023-2028 (%)
Exhibits64: Chart on Hormonal therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits65: Data Table on Hormonal therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits66: Chart on Hormonal therapy - Year-over-year growth 2023-2028 (%)
Exhibits67: Data Table on Hormonal therapy - Year-over-year growth 2023-2028 (%)
Exhibits68: Market opportunity by Modality ($ billion)
Exhibits69: Data Table on Market opportunity by Modality ($ billion)
Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits71: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits73: Chart on Geographic comparison
Exhibits74: Data Table on Geographic comparison
Exhibits75: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits104: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits105: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits107: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits108: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits109: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits110: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits111: Market opportunity By Geographical Landscape ($ billion)
Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits113: Impact of drivers and challenges in 2023 and 2028
Exhibits114: Overview on Criticality of inputs and Factors of differentiation
Exhibits115: Overview on factors of disruption
Exhibits116: Impact of key risks on business
Exhibits117: Vendors covered
Exhibits118: Matrix on vendor position and classification
Exhibits119: AbbVie Inc. - Overview
Exhibits120: AbbVie Inc. - Product / Service
Exhibits121: AbbVie Inc. - Key news
Exhibits122: AbbVie Inc. - Key offerings
Exhibits123: Amgen Inc. - Overview
Exhibits124: Amgen Inc. - Product / Service
Exhibits125: Amgen Inc. - Key offerings
Exhibits126: Apotex Inc. - Overview
Exhibits127: Apotex Inc. - Product / Service
Exhibits128: Apotex Inc. - Key offerings
Exhibits129: AstraZeneca Plc - Overview
Exhibits130: AstraZeneca Plc - Product / Service
Exhibits131: AstraZeneca Plc - Key news
Exhibits132: AstraZeneca Plc - Key offerings
Exhibits133: Bayer AG - Overview
Exhibits134: Bayer AG - Business segments
Exhibits135: Bayer AG - Key news
Exhibits136: Bayer AG - Key offerings
Exhibits137: Bayer AG - Segment focus
Exhibits138: Bristol Myers Squibb Co. - Overview
Exhibits139: Bristol Myers Squibb Co. - Product / Service
Exhibits140: Bristol Myers Squibb Co. - Key news
Exhibits141: Bristol Myers Squibb Co. - Key offerings
Exhibits142: Cipla Ltd. - Overview
Exhibits143: Cipla Ltd. - Business segments
Exhibits144: Cipla Ltd. - Key news
Exhibits145: Cipla Ltd. - Key offerings
Exhibits146: Cipla Ltd. - Segment focus
Exhibits147: Eli Lilly and Co. - Overview
Exhibits148: Eli Lilly and Co. - Product / Service
Exhibits149: Eli Lilly and Co. - Key news
Exhibits150: Eli Lilly and Co. - Key offerings
Exhibits151: F. Hoffmann La Roche Ltd. - Overview
Exhibits152: F. Hoffmann La Roche Ltd. - Business segments
Exhibits153: F. Hoffmann La Roche Ltd. - Key news
Exhibits154: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits155: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits156: GlaxoSmithKline Plc - Overview
Exhibits157: GlaxoSmithKline Plc - Business segments
Exhibits158: GlaxoSmithKline Plc - Key news
Exhibits159: GlaxoSmithKline Plc - Key offerings
Exhibits160: GlaxoSmithKline Plc - Segment focus
Exhibits161: Hikma Pharmaceuticals Plc - Overview
Exhibits162: Hikma Pharmaceuticals Plc - Business segments
Exhibits163: Hikma Pharmaceuticals Plc - Key offerings
Exhibits164: Hikma Pharmaceuticals Plc - Segment focus
Exhibits165: Merck and Co. Inc. - Overview
Exhibits166: Merck and Co. Inc. - Business segments
Exhibits167: Merck and Co. Inc. - Key news
Exhibits168: Merck and Co. Inc. - Key offerings
Exhibits169: Merck and Co. Inc. - Segment focus
Exhibits170: Novartis AG - Overview
Exhibits171: Novartis AG - Business segments
Exhibits172: Novartis AG - Key offerings
Exhibits173: Novartis AG - Segment focus
Exhibits174: Pfizer Inc. - Overview
Exhibits175: Pfizer Inc. - Product / Service
Exhibits176: Pfizer Inc. - Key news
Exhibits177: Pfizer Inc. - Key offerings
Exhibits178: Sanofi SA - Overview
Exhibits179: Sanofi SA - Business segments
Exhibits180: Sanofi SA - Key news
Exhibits181: Sanofi SA - Key offerings
Exhibits182: Sanofi SA - Segment focus
Exhibits183: Inclusions checklist
Exhibits184: Exclusions checklist
Exhibits185: Currency conversion rates for US$
Exhibits186: Research methodology
Exhibits187: Validation techniques employed for market sizing
Exhibits188: Information sources
Exhibits189: List of abbreviations